Join the b2venture community at one of our portfolio companies. See all open positions below.

Interested in working directly for b2venture? Learn more.

Scientist Translational Research and Biomarkers*

immatics biotechnologies

immatics biotechnologies

Posted on Tuesday, May 28, 2024
We are currently seeking a Scientist Translational Research and Biomarkers* to support our team in the development of innovative immunotherapeutic products. You will work in a full-time and permanent position on-site in Tübingen (Germany) in an interdisciplinary environment with colleagues from all research as well as business development and intellectual property departments.
Your mission
  • Planning, supervision, documentation and reporting of clinical Immunomonitoring data using a wide range of standardized cellular, non-cellular and molecular techniques
  • Method development in the context of translational research and clinical Immunomonitoring
  • Professional supervision of lab personnel being responsible for assay conduction
  • Development and management of assigned projects including communication with external vendors and the internal project team
  • Contribution to preparing clinical trial associated documents with a focus on immunological and Immunomonitoring associated aspects (e.g., Clinical Study Protocol, Clinical Study Report, Statistical Analysis Plan etc.)
  • Support of Quality Management including writing and reviewing of Standard Operating Procedures (SOPs)
  • Contribution to preparing regulatory documents
Your profile
You hold a PhD degree in life sciences and have a proven track record and hands-on technical experience in experimental immunology as well as cellular biology. In addition, you have in-depth understanding of cell biology and immunology, ideally in the field of cancer cell therapy. Experience with standardized cell-based functional assays and multicolor flow cytometry as well as comprehensive knowledge in cytometry analysis of complex data sets is mandatory. Expertise in pharmacokinetic studies using quantitative RT-PCR and/ or anti-drug antibody assays, ideally with the MesoScale Discovery (MSD) platform, is regarded as highly advantageous. Professional experience in a GxP environment and quality-related experience is a plus.

We expect a high degree of independent working and analytical reasoning. You have excellent communication skills, both in English and German. You are conversant with quality management systems, and you take careful editing and documenting of your results for granted. You embrace rapidly changing requirements with an open mind, think outside the box and show a high degree of flexibility in an environment which is marked by a constant striving for excellence. Your motivation is driven by your dedication to innovation and science. You approach tasks in a structured, reliable and foresighted manner, combined with an elevated level of individual responsibility, enthusiasm and strong social skills.
Why us?
We are a committed and inspired team and cherish the collegial, highly motivated and family-friendly atmosphere within Immatics. Our culture allows for a high level of originality, independent thinking and initiative. We believe in supporting our employees’ professional and social skills: We enable them to join conferences and trainings as well as to enjoy our Immatics benefits – e.g. job bike, job ticket, Health Programs, childcare benefits, relocation allowance, Company summer and winter events.
*We value diversity and inclusion. Immatics N.V. and all Immatics subsidiaries are equal opportunity employers that evaluate qualified applicants without regard to race, color, national origin, religion, sex, age, marital status, disability, veteran status, sexual orientation, gender identity, or other characteristics protected by law.
About Us
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.

This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics as well as our partnerships with global leaders in the pharmaceutical industry. We are committed to delivering the power of T cells and to unlocking new avenues for patients in their fight against cancer.